KARACHI – Gold prices in Pakistan extended their decline on October 23, losing another Rs7,000 per tola as the international market moved lower.
The latest fall brought the domestic rate to Rs424,536 per tola, while 10 grams of gold dropped by Rs6,001 to Rs363,971, as per local market rates.
Gold/Silver
New Price
Decline
Gold per tola
Rs424,536
Rs7,000
Gold per 10 grams
Rs363,971
Rs6,001
International gold per ounce
$4,020
$70
Silver per tola
Rs5,865
Rs221
Over two consecutive sessions, gold has become Rs10,000 cheaper per tola. Thursday’s trading had already seen a Rs3,000 reduction, leaving the rate at Rs431,536 before Friday’s sharper drop.
Gold Rates in Lahore
City
Item
Selling Rate
Buying
Lahore
Gold — Piece
423,700
423,200
Lahore
Gold — Pathoor
418,500
416,500
Karachi
Gold
423,500
—
Lahore
Silver — Tezabi
5,850
5,750
Lahore
Silver — 1kg Bar
5,900
5,850
The downward movement mirrored international trading, where gold fell by $70 to settle at $4,020 an ounce.
Silver also recorded a decline in Pakistan, with its per-tola price decreasing by Rs221 to Rs5,865.
Gold prices remained at Rs431,536 on Friday, amid downward trend in international bullion trends. Silver prices also recorded decline, adding to the negative trend in the country’s precious metals market.
Latest Gold and Silver Prices in Pakistan
Category
Reported Price
Gold per tola (Pakistan)
Rs431,536
Gold per 10 grams (Pakistan)
Rs369,972
International gold per ounce
$4,090
Silver per tola (Pakistan)
Rs6,086
Gold Piece (Lahore)
Rs428,500 / Rs427,500
Pathoor (Lahore)
Rs423,000 / Rs421,000
22-karat gold (Lahore)
Rs395,574
21-karat gold (Lahore)
Rs377,594
Gold selling rate (Karachi)
Rs432,500
999.0 Tezabi silver (Lahore)
Rs6,050
Silver 1-kilogram bar (Lahore)
Rs6,100
10-tola silver piece (Lahore)
Rs6,207
Gold Falls Rs3,000 Per Tola
The latest price movement brought the per-tola gold rate stood at Rs431,536 in Pakistan. The price of 10 grams also recorded a negative change, settling at Rs369,972.
The steady trend has put the spotlight on the country’s bullion market, where local prices are influenced by international gold trends, currency movements and domestic trading conditions.
Lahore, Karachi Gold Rates
Separate market quotations from Lahore showed differences across gold categories. The price of a gold piece was reported at Rs428,500, while another quoted rate stood at Rs427,500.
Pathoor gold was listed at Rs423,000 and Rs421,000. Meanwhile, the reported price of 22-karat gold reached Rs395,574, while 21-karat gold was quoted at Rs377,594.
In Karachi, the reported gold selling rate stood at Rs432,500.
Gold was not the only precious metal to lose ground. Silver prices in Pakistan also moved lower, falling by Rs121 per tola to Rs6,086, according to the supplied figures.
In Lahore, 999.0 Tezabi silver was quoted at Rs6,050, while a one-kilogram silver bar was listed at Rs6,200. The reported price of a 10-tola silver piece stood at Rs5,250.
The $30 drop in international gold prices to $4,090 per ounce coincided with the reduction in Pakistan’s local gold rates. Global bullion movements remain an important influence on domestic prices, although exchange-rate changes and local market factors can also affect the final rates.
With both gold and silver registering declines, buyers and traders will be watching closely for further movements in the international market and their potential impact on local prices.
from SGT Report: Rumble(“play”, {“video”:”v7ezifs”,”div”:”rumble_v7ezifs”}); Get PHYSICAL precious metal from SD Bullion: https://sdbullion.com/gold-silver-ira?utm_source=sgtreport FREE shipping on orders over $199 Is there a world in which a $415 silver price could exist TODAY? Yep, but only if we could have ditched the Wall Street manipulators in favor of Asia and fair trading over the pat few […]
Silver was medicine. Not alternative medicine. Not folk medicine. Medicine. In surgery. In obstetrics. In the burn ward. In water treatment. In the household medicine chest. Every physician before 1938 knew this.
By the 1870s, silver nitrate was standard in surgical wound care across the leading hospitals of Britain, Germany, and the United States. Colloidal silver preparations — Collargol, Argyrol, Protargol — entered European and American practice through the 1890s and early 1900s and became standard antiseptics in military field medicine. By the time Fleming grew his first penicillin mould in 1928, silver was the first-line antimicrobial of the Western pharmacopoeia. The Lancet and the British Medical Journal carried the clinical reports in volume. The practice ran continuously through the Victorian era, the Edwardian era, the First World War, the interwar period. By 1980, almost all of it was gone.
What has not been treated at book length, until now, is how a four-thousand-year clinical record disappeared from mainstream medicine within four decades of the Flexner Report — and what the honest account of silver looks like once that record is reassembled.
Colloidal Silver reconstructs the pre-1938 record from The Lancet, the British Medical Journal, and the primary literature of the era; recovers Robert Becker’s bioelectric framework from the regeneration research the pharmaceutical model buried; and places silver inside a practical terrain-paradigm guide to its current place — in water, on the body, inside the body, and in the chronic conditions where antibiotics have failed.
Honest about argyria. Honest about what silver cannot do. Honest about the dependency trap.
That is why the book has ten appendices. 295 pages, thirteen chapters, ten appendices. The practical use chapters are grounded in a reference apparatus — a Pre-1938 Condition Index with two hundred and forty entries, an Argyria File, resources, commercial products, modern case accounts, cleansing responses, children and vulnerable populations. The whole picture, in one place.
The seed idea, and the person who planted it
The frame that lets this book say what silver is actually doing came from Robert Becker. Becker was the orthopaedic surgeon at Upstate Medical Center in Syracuse and the Syracuse VA whose electrical regeneration research in the 1960s and 70s named something no one else was willing to name at the time: silver is not just an antimicrobial. It is a bioelectric agent. His silver-electrode experiments regrew tissue in animals that mainstream medicine said was non-regenerable. His book The Body Electric (1985) is the full account.
Becker is the frame that lets Colloidal Silver explain what silver is actually doing — not just “killing bacteria,” but acting on the bioelectric field the pharmaceutical model has no vocabulary for. His regeneration research was systematically defunded through the 1980s because an element on the periodic table has no business plan. Chapter 6 of this book rebuilds the Becker framework from the primary research he published before the funding stopped.
The debt is foundational, and belongs at the top of the post.
What the book shows
Part One: The Disappearance. What silver did in Western medicine for a century before 1938, and how it vanished. The surgical wound-care tradition and the pre-antibiotic clinical record. The Lancet and BMJ as the primary archive. The Flexner Report of 1910, funded by Carnegie and Rockefeller, which restructured American medical education around the pharmaceutical model and killed silver’s institutional base inside a generation. The Streetlight Effect — why the questions silver could answer stopped being asked once the funding model changed. The first section is the recovered history, put together in one place for the first time.
Part Two: What Silver Is and What It Isn’t. Why the germ theory story fails as a complete account of infection. The terrain paradigm as the actual working frame of pre-1938 medicine, before Pasteur-only orthodoxy was institutionalised. What silver actually does at the cellular level — Becker’s bioelectric framework in full — and what the pharmaceutical model has to keep denying for the current therapeutic approach to continue to work.
Part Three: Practical Use. Three parallel chapters: silver and water, silver on the body, silver inside the body. Preparation. Dosing. What distinguishes clinically useful colloidal silver from the commercial product that gets sold as a tonic. What forms work for what conditions. The practical heart of the book.
Part Four: The Honest Account. Argyria and the historical silver compounds — the condition that gets used to end every conversation about silver, correctly identified so it stops ending the conversation. When antibiotics have failed and silver is the one tool still working. What silver cannot do. The place of silver in a terrain approach — not as a replacement for anything, not as a cure-all, as one tool returned to the shelf, with its evidence intact.
What is at the back
Ten appendices. Home Production of Colloidal Silver — equipment, concentration, safety. Dosing and Administration. The Pre-1938 Condition Index, two hundred and forty entries from the primary literature, condition by condition, source by source. The Argyria File — every documented case the research could identify and the circumstances that produced it. Resources and Further Reading. Commercial Products. Modern Case Accounts. Silver in the Broader Landscape of Recovered Remedies. Understanding Cleansing Responses. Children, Pregnancy, and Vulnerable Populations.
Full back-of-book index. Everything cross-referenced.
Who this book is for
If you have been reading me on Substack for a while and you have been waiting for the one book on silver that holds the pre-1938 record, the Becker framework, and the practical use together, this is that book.
If you are new, start here. You do not need to have read anything else to follow it.
If someone you love is still working through chronic infection, long-course antibiotic damage, or the dependency trap of pharmaceutical-only medicine, this is the one volume I would send.
If Colloidal Silver traces how one of the pre-1938 tools was dropped, No Autoimmunity takes apart the diagnostic category that was invented to explain what medicine has done to the body in the years since.
The current chronic-illness landscape — type 1 diabetes, juvenile arthritis, pediatric multiple sclerosis, thyroid disease, atopic dermatitis, food anaphylaxis — is routinely labelled “autoimmune.” The word places the fault inside the patient. The body is said to have malfunctioned, failed to tell self from non-self, started attacking itself.
The body did not do any of that. The body responded to what has been injected past every barrier it has to filter foreign material. The mechanism was named more than a hundred years ago, confirmed experimentally through the twentieth century, and relabelled only when the original vocabulary stopped suiting the business model. No Autoimmunity is the full account.
Readers who want the pre-1938 pharmacopoeia restored, tool by tool, should read Colloidal Silver. Readers who want the “autoimmune” label dismantled should read No Autoimmunity. The two sit together on the shelf, and the pair reinforces.